Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hitesh N. Gandhi"'
Autor:
Jehan Alladina, Peter P Moschovis, Hitesh N Gandhi, Donna Carstens, Elizabeth D Bacci, Katelyn Cutts, Karin S Coyne, Karen Goldsborough, Dawei Jiang, Conor O’Brien, T Bernard Kinane
Publikováno v:
Digital Health, Vol 10 (2024)
Objective Asthma is often inadequately controlled, which can result in exacerbations that lead to unplanned healthcare visits. Mobile application (app) use could help manage asthma exacerbations. We implemented the Amaze™ asthma disease management
Externí odkaz:
https://doaj.org/article/5668c45f784542d8a69f844223efb02c
Autor:
Bradley Chipps, Robert S. Zeiger, David A. Beuther, Joan Reibman, Robert A. Wise, William McCann, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Gale Harding, Katelyn Cutts, Maureen George, Kevin R. Murphy
Publikováno v:
Annals of Allergy, Asthma & Immunology.
Autor:
BARBARA P YAWN, JONATHAN N. TOBIN, JO ANN BROOKS, KENNETH MENDEZ, SIDDHARTHA SINGH, ILEEN GILBERT, JAMES M EUDICONE, HITESH N GANDHI, GALE S HARDING, MARY K LADD, DAVID A BEUTHER
Publikováno v:
Chest. 162:A45-A47
Publikováno v:
Chest. 162:A50-A51
Publikováno v:
Chest. 162:A48-A49
Autor:
David A. Beuther, Kevin R. Murphy, Robert S. Zeiger, Robert A. Wise, William McCann, Joan Reibman, Maureen George, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Melissa Ross, Karin S. Coyne, Bradley Chipps
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 10:3204-3212.e2
The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, equally weighted, yes/no control tool validated in patients with asthma aged 12 years and older.To evaluate AIRQ's ability to predict patient-reported exacerbations over 12 months.Pati
Autor:
Bradley E. Chipps, Kevin R. Murphy, Robert A. Wise, William A. McCann, David A. Beuther, Joan Reibman, Maureen George, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Gale Harding, Melissa Ross, Robert S. Zeiger
Publikováno v:
Annals of Allergy, Asthma & Immunology. 128:544-552.e3
Recurrent assessment of asthma control is essential to evaluating disease stability and intervention impacts. An assessment that can be administered between annual clinic visits is needed. The Asthma Impairment and Risk Questionnaire (AIRQ) is a cros